Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Straiker $64M Series ASigma Computing $80M Series ERanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Straiker $64M Series ASigma Computing $80M Series ENew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
X Square Robot Undisclosed Series CHuixi Technology >$50M Angel+New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Almetra €16.3M Series ATalkiatry $210M Series DNew companies 2 · Follow-on 0
Stages: Series B 2
Ollin Biosciences $330M Series BHomeward $136M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
xCures $46M Series BSewerAI Undisclosed StrategicNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Stegra €1.4B GrowthAfresh $34M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
RQ Bio $115M Series AExciva €51M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Platformr $10M UndisclosedArpio $15M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Stegra €1.4B GrowthTurbine Capital Fund I SEK 608M Fund I — final closeNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
JUPUS €13M Series AConvelio Undisclosed Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Ladder Health $7M SeedHLRBO $2.5M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Osanni Bio $190M Series BLXE Hearing $100M Merger-related investmentNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TRIMTECH Therapeutics $47M Seed+Semarion $3.8M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Peregrine Technologies $250M Series DVital Signals $15M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Bionyra Pharma $165M Series ACrossbow Therapeutics $77M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Bionyra Pharma $165M Series AAdcendo $75M Series CNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series C+ 1
Nearfield Instruments $380M Series DTouchwaves €1.5M Pre-SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Syntax Bio $14.4M Series A+Sidewinder Therapeutics $137M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Dream $260M UndisclosedPlata $405M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.